herbimycin has been researched along with Leukemia--T-Cell* in 1 studies
1 other study(ies) available for herbimycin and Leukemia--T-Cell
Article | Year |
---|---|
Established IL-2-dependent double-negative (CD4- CD8-) TCR alpha beta/CD3+ ATL cells: induction of CD4 expression.
We established IL-2-dependent T cells from an adult T-cell leukaemia (ATL) patient whose leukaemic cells changed from CD4 single-positive in the initial phase to double-negative (CD4- CD8-) at the time of exacerbation. The cells termed SO-4 were of ATL cell origin and showed the double-negative TCR alpha beta/CD3+ T-cell phenotype. SO-4 cells acquired CD4 antigen expression following stimulation with concanavalin A (ConA) or immobilized anti-CD3 antibody. The induction was inhibited by herbimycin A, an inhibitor of protein tyrosine kinase (PTK) activity. No CD4 mRNA was detectable in unstimulated SO-4 cells but a 3.0 kb signal specific for CD4 mRNA was detected after stimulation. These findings indicate that SO-4 cells return to their original phenotype (CD4 single-positive) by stimulation involving PTK. The results indicate that there is a pathway of phenotypic cycling between CD4 single-positive and double-negative T cells. Topics: Benzoquinones; Blotting, Northern; Blotting, Southern; CD3 Complex; CD4 Antigens; CD8 Antigens; Concanavalin A; Female; Gene Expression; Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; Humans; Interleukin-2; Lactams, Macrocyclic; Leukemia, T-Cell; Middle Aged; Protein-Tyrosine Kinases; Quinones; Receptors, Antigen, T-Cell, alpha-beta; Rifabutin; RNA, Messenger; T-Lymphocyte Subsets; Tumor Cells, Cultured | 1994 |